| 0 |
MULTIPLE GATED ACQUISITION SCAN ABNORMAL |
1 |
0.0233 |
| 1 |
CONFUSIONAL AROUSAL |
1 |
0.0062 |
| 2 |
CEREBRAL AMYLOID ANGIOPATHY |
1 |
0.0030 |
| 3 |
PORTAL HYPERTENSIVE GASTROPATHY |
1 |
0.0018 |
| 4 |
PLEURAL THICKENING |
1 |
0.0015 |
| 5 |
LYMPHANGIOSIS CARCINOMATOSA |
1 |
0.0010 |
| 6 |
UTERINE DISORDER |
1 |
0.0004 |
| 7 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 8 |
DERMAL CYST |
1 |
0.0004 |
| 9 |
DYSAESTHESIA |
1 |
0.0003 |
| 10 |
FIBROSIS |
1 |
0.0003 |
| 11 |
PALLOR |
7 |
0.0003 |
| 12 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 13 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 14 |
FOOT OPERATION |
1 |
0.0002 |
| 15 |
AMMONIA INCREASED |
1 |
0.0002 |
| 16 |
SKIN NECROSIS |
1 |
0.0002 |
| 17 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 18 |
TONGUE DISORDER |
1 |
0.0001 |
| 19 |
TROPONIN INCREASED |
1 |
0.0001 |
| 20 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 21 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 22 |
MYOPATHY |
1 |
0.0001 |
| 23 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 24 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 25 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 26 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 27 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 28 |
SCAR |
1 |
0.0001 |
| 29 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 30 |
TOOTH LOSS |
1 |
0.0000 |
| 31 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 32 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 33 |
HYPERSOMNIA |
1 |
0.0000 |
| 34 |
DYSSTASIA |
1 |
0.0000 |
| 35 |
HEAD INJURY |
1 |
0.0000 |
| 36 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 37 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 38 |
EYE SWELLING |
1 |
0.0000 |
| 39 |
THROAT IRRITATION |
1 |
0.0000 |
| 40 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 41 |
CELLULITIS |
1 |
0.0000 |
| 42 |
THERAPY CESSATION |
1 |
0.0000 |
| 43 |
ILLNESS |
2 |
0.0000 |
| 44 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 45 |
CONVULSION |
1 |
0.0000 |
| 46 |
CHILLS |
2 |
0.0000 |
| 47 |
CATARACT |
1 |
0.0000 |
| 48 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 49 |
RHINORRHOEA |
1 |
0.0000 |
| 50 |
AMNESIA |
1 |
0.0000 |
| 51 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 52 |
INJURY |
1 |
0.0000 |
| 53 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 54 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 55 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 56 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 57 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 58 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 59 |
FLUSHING |
1 |
0.0000 |
| 60 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 61 |
SEPSIS |
1 |
0.0000 |
| 62 |
SEIZURE |
1 |
0.0000 |
| 63 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 64 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 65 |
NEUTROPENIA |
1 |
0.0000 |
| 66 |
HYPOAESTHESIA |
1 |
0.0000 |
| 67 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 68 |
PNEUMONIA |
2 |
0.0000 |
| 69 |
TREMOR |
1 |
0.0000 |
| 70 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 71 |
COVID-19 |
1 |
0.0000 |
| 72 |
MUSCLE SPASMS |
1 |
0.0000 |
| 73 |
CHEST PAIN |
1 |
0.0000 |
| 74 |
ASTHENIA |
2 |
0.0000 |
| 75 |
ANAEMIA |
1 |
0.0000 |
| 76 |
ERYTHEMA |
1 |
0.0000 |
| 77 |
DEATH |
4 |
0.0000 |
| 78 |
WEIGHT INCREASED |
1 |
0.0000 |
| 79 |
DECREASED APPETITE |
1 |
0.0000 |
| 80 |
FEELING ABNORMAL |
1 |
0.0000 |
| 81 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 82 |
COUGH |
1 |
0.0000 |
| 83 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 84 |
FALL |
1 |
0.0000 |
| 85 |
PYREXIA |
1 |
0.0000 |
| 86 |
PRURITUS |
1 |
0.0000 |
| 87 |
OFF LABEL USE |
2 |
0.0000 |
| 88 |
DIZZINESS |
1 |
0.0000 |
| 89 |
DYSPNOEA |
1 |
0.0000 |
| 90 |
PAIN |
1 |
0.0000 |
| 91 |
DIARRHOEA |
1 |
0.0000 |
| 92 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 93 |
FATIGUE |
1 |
0.0000 |